Sertraline approved for post-traumatic stress disorderBMJ 1999; 319 doi: http://dx.doi.org/10.1136/bmj.319.7217.1089 (Published 23 October 1999) Cite this as: BMJ 1999;319:1089
- Scott Gottlieb
- New York
The US Food and Drug Administration's psychopharmacologic drugs advisory committee voted six to one to recommend that the agency approve the use of the popular antidepressant drug sertraline for treatment of post-traumatic stress disorder.
If the drug gains approval it will be the first drug officially available for the disorder. It is likely to carry labelling, however, noting that its efficacy has not been established in men.
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial